The economic burden of visceral leishmaniasis in Sudan: An assessment of provider and household costs

American Journal of Tropical Medicine and Hygiene

Volumn 89, Issue 6, 2013, Pages 1146-1153

  Meheus, Filip ^a,b   Abuzaid, Abuzaid A ^c   Baltussen, Rob ^d   Younis, Brima M ^e   Balasegaram, Manica ^f   Khalil, Eltahir A G ^e   Boelaert, Marleen ^b   Musa, Ahmed M ^e  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^c UNIVERSITY OF KHARTOUM   (Sudan)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF KHARTOUM   (Sudan)

^f Drugs for Neglected Diseases Initiative   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEISHMANIAL AGENT; STIBOGLUCONATE SODIUM;

ADOLESCENT; ADULT; ARTICLE; CHILD; COST OF ILLNESS; DIARRHEA; ECONOMIC ASPECT; FEMALE; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH PERSONNEL ATTITUDE; HEART ARRHYTHMIA; HOSPITAL COST; HOUSEHOLD; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MYALGIA; NAUSEA; PANCREATITIS; PRESCHOOL CHILD; PRIVATE PRACTICE; PUBLIC HOSPITAL; SCHOOL CHILD; SUDAN; TREATMENT DURATION; VISCERAL LEISHMANIASIS;

EID: 84890379192     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.12-0585     Document Type: Article

References (39)

1. MurrayHW, BermanJD, DaviesCR, SaraviaNG, 2005. Advances in leishmaniasis. Lancet 366: 1561-1577.
2. MeheusF, BoelaertM, BaltussenR, SundarS, 2006. Costs of patient management of visceral leishmaniasis in Muzaffarpur, Bihar, India. Trop Med Int Health 11: 1715-1724.
3. SharmaAD, BernC, VargheseB, ChowdhuryR, HaqueR, AliM, AmannJ, AhluwaliaIB, WagatsumaY, BreimanRF, MaguireJH, McFarlandDA, 2006. The economic impact of visceral leishmaniasis on households in Bangladesh. Trop Med Int Health 11: 757-764.
4. UranwS, MeheusF, BaltussenR, RijalS, BoelaertM, 2013. The economic burden of visceral leishmaniasis on households in eastern Nepal. PLoS Negl Trop Dis 7: e2062.
5. Central Bureau of Statistics Sudan, 2011. Fifth Population and Housing Census 2008. Available at: http://www.cbs.gov.sd/en/node/6. Accessed July 15, 2012.
6. CollinSM, ColemanPG, RitmeijerK, DavidsonRN, 2006. Unseen Kala-azar deaths in south Sudan (1999-2002). Trop Med Int Health 11: 509-512.
7. DesjeuxP, 1996. Leishmaniasis: public health aspects and control. Clin Dermatol 14: 417-423.
8. WHO, 2006. Health System Profile Sudan. Cairo, Egypt: WHO Regional Office for the Eastern Mediterranean.
9. Malaria Consortium, 2010. Leishmaniasis Control in Eastern Africa: Past and Present Efforts and Future Needs.
10. RitmeijerK, DaviesC, van ZorgeR, WangSJ, SchorscherJ, Dongu'duSI, DavidsonRN, 2007. Evaluation of a mass distribution programme for fine-mesh impregnated bed nets against visceral leishmaniasis in eastern Sudan. Trop Med Int Health 12: 404-414.
11. Federal Ministry of Health Sudan, 2004. Manual for diagnosis and treatment of leishmaniasis. Federal Ministry of Health: Leishmaniasis Administration.
12. RijalS, ChappuisF, SinghR, BovierPA, AcharyaP, KarkiBM, DasML, DesjeuxP, LoutanL, KoiralaS, 2003. Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline. Trans R Soc Trop Med Hyg 97: 350-354.
13. SundarS, MoreDK, SinghMK, SinghVP, SharmaS,MakhariaA, KumarPC, MurrayHW, 2000. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin Infect Dis 31: 1104-1107.
14. HailuA,MusaA,WasunnaM, BalasegaramM, YifruS, MengistuG, HurissaZ, HailuW, WeldegebrealT, TesfayeS, MakonnenE, KhalilE, AhmedO, FadlallaA, El-HassanA, RaheemM, MuellerM, KoummukiY, RashidJ, MbuiJ, MuceeG, NjorogeS, MandukuV, MusibiA, MutumaG, KiruiF, LodenyoH, MuteaD, KirigiG, EdwardsT, SmithP, MuthamiL, RoyceC, EllisS, AloboM, OmolloR, KesusuJ, OwitiR, KinuthiaJ, 2010. Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial. PLoS Negl Trop Dis 4: e709.
15. MelakuY, CollinSM, KeusK, GatluakF, RitmeijerK, DavidsonRN, 2007. Treatment of kala-azar in southern Sudan using a 17-day regimen of sodium stibogluconate combined with paromomycin: a retrospective comparison with 30-day sodium stibogluconate monotherapy. Am J Trop Med Hyg 77: 89-94.
16. MusaA, KhalilE, HailuA, OloboJ, BalasegaramM, OmolloR, EdwardsT, RashidJ,MbuiJ,MusaB, AbuzaidAA, AhmedO, FadlallaA, El-HassanA, MuellerM, MuceeG, NjorogeS, MandukuV, MutumaG, ApadetL, LodenyoH, MuteaD, KirigiG, YifruS, MengistuG, HurissaZ, HailuW, WeldegebrealT, TafesH, MekonnenY, MakonnenE, NdegwaS, SagakiP, KimutaiR, KesusuJ, OwitiR, EllisS, WasunnaM, 2012. Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomized controlled trial. PLoS Negl Trop Dis 6: e1674.
17. OmolloR, AlexanderN, EdwardsT, KhalilEA, YounisBM, AbuzaidAA, WasunnaM, NjorogeN, KinotiD, KirigiG, DorloTP, EllisS, BalasegaramM, MusaAM, 2011. Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial. Trials 12: 166.
18. ZijlstraEE, AliMS, el-HassanAM, el-ToumIA, SattiM, GhalibHW, KagerPA, 1992. Kala-azar: a comparative study of parasitological methods and the direct agglutination test in diagnosis. Trans R Soc Trop Med Hyg 86: 505-507.
19. ZijlstraEE, el-HassanAM, 2001. Leishmaniasis in Sudan. Visceral leishmaniasis. Trans R Soc Trop Med Hyg 95 (Suppl 1): S27-S58.
20. CollinS, DavidsonR, RitmeijerK, KeusK, MelakuY, KipngetichS, DaviesC, 2004. Conflict and kala-azar: determinants of adverse outcomes of kala-azar among patients in southern Sudan. Clin Infect Dis 38: 612-619.
21. HansenK, ChapmanG, ChitsikeI, KasiloO, MwalukoG, 2000. The costs of HIV/AIDS care at government hospitals in Zimbabwe. Health Policy Plan 15: 432-440.
22. McPakeB, HongoroC, RussoG, 2011. Two-tier charging in Maputo Central Hospital: costs, revenues and effects on equity of access to hospital services. BMC Health Serv Res 11: 143.
23. Van der PlaetseB, HlatiwayoG, VanEL, MeessenB, CrielB, 2005. Costs and revenue of health care in a rural Zimbabwean district. Health Policy Plan 20: 243-251.
24. CreeseA, ParkerD, 1994. Cost Analysis in Primary Health Care: A Training Manual for Programme Managers. Geneva: World Health Organization.
25. WHO, 2010. Control of the Leishmaniasis: Report of a Meeting of the WHO Expert Committee on the Control of Leishmaniasis. Geneva: WHO.
26. WHO-CHOICE. Country-specific unit costs. Available at: http://www.who.int/choice/country/country-specific/en/index.html. Accessed July 15, 2012.
27. DrummondM, SculpherMJ, TorranceGW, O'BienBJ, StoddartGL, 2005. Methods for the Economic Evaluation of Health Care Programmes. Third edition. Oxford: Oxford University Press.
28. GoldMR, RussellLB, SiegelJE, WeinsteinMC, 1996. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press.
29. ContehL, WalkerD, 2004. Cost and unit cost calculations using step-down accounting. Health Policy Plan 19: 127-135.
30. O'DonnellO, van DoorslaerE, WagstafA, LindelowM, 2008. Analyzing Health Equity Using Household Survey Data: A Guide to Techniques and Their Implementation . Washington, DC: The World Bank.
31. RansonMK, 2002. Reduction of catastrophic health care expenditures by a community-based health insurance scheme in Gujarat, India: current experiences and challenges. Bull World Health Organ 80: 613-621.
32. World Bank. World databank: World development indicators & Global development finance. Available at: http://data.worldbank.org/indicator/FP.CPI. TOTL. Accessed July 15, 2012.
33. RijalS, KoiralaS, Van der StuyftP, BoelaertM, 2006. The economic burden of visceral leishmaniasis for households in Nepal. Trans R Soc Trop Med Hyg 100: 838-841.
34. SarnoffR, DesaiJ, DesjeuxP, MittalA, TopnoR, SiddiquiNA, PandeyA, SurD, DasP, 2010. The economic impact of visceral leishmaniasis on rural households in one endemic district of Bihar, India. Trop Med Int Health 15 (Suppl 2): 42-49.
35. SundarS, AroraR, SinghSP, BoelaertM, VargheseB, 2010. Household cost-of-illness of visceral leishmaniasis in Bihar, India. Trop Med Int Health 15 (Suppl 2): 50-54.
36. HarhayMO, OlliaroPL, VaillantM, ChappuisF, LimaMA, RitmeijerK, CostaCH, CostaDL, RijalS, SundarS, BalasegaramM, 2011. Who is a typical patient with visceral leishmaniasis? Characterizing the demographic and nutritional profile of patients in Brazil, East Africa, and South Asia. Am J Trop Med Hyg 84: 543-550.
37. GerstlS, AmsaluR, RitmeijerK, 2006. Accessibility of diagnostic and treatment centres for visceral leishmaniasis in Gedaref State, northern Sudan. Trop Med Int Health 11: 167-175.
38. EdwardsT, OmolloR, KhalilEA, YifruS, MusaB, MusaA, WasunnaM, SmithPG, RoyceC, EllisS, BalasegaramM, HailuA, 2011. Single-dose liposomal amphotericin B (AmBisome(R)) for the treatment of visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial. Trials 12: 66.
39. BurkiT, 2012. Drug donated for treatment of visceral leishmaniasis. Lancet Infect Dis 12: 106-107.